Skip to main content
Caplight Logo









Vivtex

Vivtex

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://vivtex.com/

Last Round

Accelerator

May 9, 2024

Total Funding Raised

$1.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Vivtex is a biotechnology company that operates a healthcare platform for drug development using robotic technology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

oral biologicsdrug delivery platforminjectable to oraloral peptidesGI-ORIS platformdrug co-developmentrobotic screeninghigh-throughput screeningHTSoral absorption predictiondrug formulationGastrointestinal Organ Robotic Interface Systemex vivo screeningbiologic therapeuticsdrug development royalties

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vivtex Comparables

Compare Vivtex with similar companies based on industry and business-model similarity.

Vivtex comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
i2O Therapeutics
87%
Cyprumed GmbH
80%
Biograil
79%

Vivtex Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMay 9, 2024
Convertible DebtAug 19, 2022

Key People

Founding team and executive leadership

Thomas von Erlach

Co-Founder And CEO

Founding Team

Vivtex Investors

Notable investors and investment history

Vivtex investors
InvestorRounds
The Elizabeth Elting Venture FundAccelerator
Endless Frontier LabsAccelerator
Portal InnovationsConvertible Debt

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 19, 2026

    Grew 20% QoQ, from 20 to 24 employees.

  • Jan 25, 2026

    Grew 17% QoQ, from 18 to 21 employees.

Vivtex Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Vivtex Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Vivtex's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range24
Year Founded2018
Last FundingMay 9, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?